SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-18-065763
Filing Date
2018-12-20
Accepted
2018-12-20 17:00:35
Documents
1
Period of Report
2018-12-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 tv509621_form4.html 4  
1 FORM 4 tv509621_form4.xml 4 3040
  Complete submission text file 0001144204-18-065763.txt   4716
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Issuer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 112 W. 34TH STREET, 17TH FLOOR NEW YORK NY 10120
Business Address
Dukes Iain D. (Reporting) CIK: 0001681955 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36860 | Film No.: 181246808